Oric orders up $50m for series C

Feb 22, 2018 • Robert Lavine

Taiho Ventures has come on board as an investor, in a round that increased the cancer drug developer's total funding to almost $120m.

US-based oncology drug developer Oric Pharmaceuticals closed a $50m series C round on Wednesday that included Taiho Ventures, the corporate venturing subsidiary of pharmaceutical company Taiho.

Cancer researcher Memorial Sloan Kettering Cancer Center, financial services group Fidelity Management & Research Company, Trinitas Capital, NS Investment, The Column Group, Topspin Fund, OrbiMed, EcoR1 Capital, Kravis Investment Partners and Foresite Capital also took part in the round.

Founded in 2014, Oric is working on drugs for treatment-resistant cancers. Its lead candidate, ORIC-101,…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

CVC DIRECTORY

Find details about global CVC units in the CVC Directory

SPECIAL REPORT

Bumpy road: Self-driving cars make a cautious comeback

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

Is now the right time to invest in autonomous driving?

Feb 19, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Apr 8 -
Apr 10, 2025
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Apr 24 -
Jun 12, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.